Structural Basis of DNA Recognition by p53 Tetramers

Molecular Cell

Volumn 22, Issue 6, 2006, Pages 741-753

  Kitayner, Malka ^a   Rozenberg, Haim ^a   Kessler, Naama ^a   Rabinovich, Dov ^a   Shaulov, Lihi ^b   Haran, Tali E ^b   Shakked, Zippora ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

CELLCYCLE; DNA

Indexed keywords

DIMER; DNA; PROTEIN P53; TETRAMER;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

APOPTOSIS; BINDING SITES; CELL CYCLE; CRYSTALLOGRAPHY, X-RAY; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; MODELS, MOLECULAR; NEOPLASMS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745209412     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.05.015     Document Type: Article

References (61)

1. Ahn J., and Prives C. The C-terminus of p53: the more you learn the less you know. Nat. Struct. Biol. 8 (2001) 730-732
2. An W., Kim J., and Roeder R.G. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117 (2004) 735-748
3. Bell S., Klein C., Muller L., Hansen S., and Buchner J. p53 contains large unstructured regions in its native state. J. Mol. Biol. 322 (2002) 917-927
4. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
5. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
6. Bullock A.N., and Fersht A.R. Rescuing the function of mutant p53. Nat. Rev. Cancer 1 (2001) 68-76
7. Cain C., Miller S., Ahn J., and Prives C. The N terminus of p53 regulates its dissociation from DNA. J. Biol. Chem. 275 (2000) 39944-39953
8. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 (1994) 346-355
9. Clore G.M., Ernst J., Clubb R., Omichinski J.G., Kennedy W.M., Sakaguchi K., Appella E., and Gronenborn A.M. Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat. Struct. Biol. 2 (1995) 321-333
10. Dehner A., Klein C., Hansen S., Muller L., Buchner J., Schwaiger M., and Kessler H. Cooperative binding of p53 to DNA: regulation by protein-protein interactions through a double salt bridge. Angew. Chem. Int. Ed. Engl. 44 (2005) 5247-5251
11. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, California
12. Derbyshire D.J., Basu B.P., Serpell L.C., Joo W.S., Date T., Iwabuchi K., and Doherty A.J. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21 (2002) 3863-3872
13. El-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1 (1992) 45-49
14. Espinosa J.M., and Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8 (2001) 57-69
15. Friedman P.N., Chen X., Bargonetti J., and Prives C. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl. Acad. Sci. USA 90 (1993) 3319-3323
16. Funk W.D., Pak D.T., Karas R.H., Wright W.E., and Shay J.W. A transcriptionally active DNA binding site for human p53 protein complexes. Mol. Cell. Biol. 12 (1992) 2866-2871
17. Gorina S., and Pavletich N.P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274 (1996) 1001-1005
18. Haran T.E., Joachimiak A., and Sigler P.B. The DNA target of the trp repressor. EMBO J. 11 (1992) 3021-3030
19. Inga A., Storici F., Darden T.A., and Resnick M.A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol. 22 (2002) 8612-8625
20. Jayaraman L., and Prives C. Covalent and noncovalent modifiers of the p53 protein. Cell. Mol. Life Sci. 55 (1999) 76-87
21. Jeffrey P.D., Gorina S., and Pavletich N.P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267 (1995) 1498-1502
22. Joo W.S., Jeffrey P.D., Cantor S.B., Finnin M.S., Livingston D.M., and Pavletich N.P. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16 (2002) 583-593
23. Kaeser M.D., and Iggo R.D. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99 (2002) 95-100
24. Kim E., and Deppert W. The versatile interactions of p53 with DNA: when flexibility serves specificity. Cell Death Differ. 13 (2006) 885-889
25. Klein C., Planker E., Diercks T., Kessler H., Kunkele K.P., Lang K., Hansen S., and Schwaiger M. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA. J. Biol. Chem. 276 (2001) 49020-49027
26. Ko J., and Prives C. p53: puzzle and paradigm. Genes Dev. 10 (1996) 1054-1072
27. Lavery R., and Sklenar H. Defining the structure of irregular nucleic acids: conventions and principles. J. Biomol. Struct. Dyn. 6 (1989) 655-667
28. Lee W., Harvey T.S., Yin Y., Yau P., Litchfield D., and Arrowsmith C.H. Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1 (1994) 877-890
29. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
30. Liu Y., Lagowski J.P., Vanderbeek G.E., and Kulesz-Martin M.F. Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain. Cancer Biol. Ther. 3 (2004) 1102-1108
31. Luscombe N.M., Laskowski R.A., and Thornton J.M. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res. 29 (2001) 2860-2874
32. May P., and May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18 (1999) 7621-7636
33. McKinney K., Mattia M., Gottifredi V., and Prives C. p53 linear diffusion along DNA requires its C terminus. Mol. Cell 16 (2004) 413-424
34. McLure K.G., and Lee P.W.K. How p53 binds DNA as a tetramer. EMBO J. 17 (1998) 3342-3350
35. Mittl P.R., Chene P., and Grutter M.G. Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 86-89
36. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
37. Nagaich A., Zhurkin V.B., Durrel S.R., Jernigan R.L., Appella E., and Harrington R.E. p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increses DNA twisting. Proc. Natl. Acad. Sci. USA 96 (1999) 1875-1880
38. Olivier M., Eeles R., Hollstein M., Khan M.A., Harris C.C., and Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat. 19 (2002) 607-614
39. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 10 (2003) 431-442
40. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter Jr. C.W., and Sweet M. (Eds). Methods in Enzymology (1997), Academic Press, New York 307-326
41. Prives C., and Hall P.A. The p53 pathway. J. Pathol. 187 (1999) 112-126
42. Qian H., Wang T., Naumovski L., Lopez C.D., and Brachmann R.K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21 (2002) 7901-7911
43. Resnick-Silverman L., St Clair S., Maurer M., Zhao K., and Manfredi J.J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev. 12 (1998) 2102-2107
44. Rippin T.M., Freund S.M., Veprintsev D.B., and Fersht A.R. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding. J. Mol. Biol. 319 (2002) 351-358
45. Rohaly G., Chemnitz J., Dehde S., Nunez A.M., Heukeshoven J., Deppert W., and Dornreiter I. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122 (2005) 21-32
46. Samuels-Lev Y., O'Connor D.J., Bergamaschi D., Trigiante G., Hsieh J.K., Zhong S., Campargue I., Naumovski L., Crook T., and Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8 (2001) 781-794
47. Slickers P., Hillebrand M., Kittler L., Lober G., and Suhnel J. Molecular modelling and footprinting studies of DNA minor groove binders: bisquaternary ammonium heterocyclic compounds. Anticancer Drug Des. 13 (1998) 463-488
48. Szak S.T., Mays D., and Pietenpol J.A. Kinetics of p53 binding to promoter sites in vivo. Mol. Cell. Biol. 21 (2001) 3375-3386
49. Thornborrow E.C., and Manfredi J.J. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J. Biol. Chem. 274 (1999) 33747-33756
50. Veprintsev D.B., Freund S.M., Andreeva A., Rutledge S.E., Tidow H., Canadillas J.M., Blair C.M., and Fersht A.R. Core domain interactions in full-length p53 in solution. Proc. Natl. Acad. Sci. USA 103 (2006) 2115-2119
51. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
52. von Hippel P.H., and Berg O.G. Facilitated target location in biological systems. J. Biol. Chem. 264 (1989) 675-678
53. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
54. Walker D.R., Bond J.P., Tarone R.E., Harris C.C., Makalowski W., Boguski M.S., and Greenblatt M.S. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 18 (1999) 211-218
55. Wang Y., Schwedes J.F., Parks D., Mann K., and Tegtmeyer P. Interaction of p53 with its consensus DNA-binding site. Mol. Cell. Biol. 15 (1995) 2157-2165
56. Waterman J.L., Shenk J.L., and Halazonetis T.D. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14 (1995) 512-519
57. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
58. Weinberg R.L., Veprintsev D.B., and Fersht A.R. Cooperative binding of tetrameric p53 to DNA. J. Mol. Biol. 341 (2004) 1145-1159
59. Weinberg R.L., Veprintsev D.B., Bycroft M., and Fersht A.R. Comparative binding of p53 to its promoter and DNA recognition elements. J. Mol. Biol. 348 (2005) 589-596
60. Wolcke J., Reimann M., Klumpp M., Gohler T., Kim E., and Deppert W. Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding. J. Biol. Chem. 278 (2003) 32587-32595
61. Zhao K., Chai X., Johnston K., Clements A., and Marmorstein R. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution. J. Biol. Chem. 276 (2001) 12120-12127